(Q33611600)

28 July 2017

1 reference

title

Estrogen receptor as a target for the prevention of breast cancer (English)

1 reference

28 July 2017

1

Jordan VC

1 reference

28 July 2017

1 May 1999

1 reference

28 July 2017

Translational Research

1 reference

28 July 2017

133

1 reference

28 July 2017

408-414

1 reference

28 July 2017

5

1 reference

Effects of intensive sex steroid hormone therapy in advanced breast cancer

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Hormone therapy for advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Tamoxifen (antiestrogen) therapy in advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

A receptor molecule for estrogens: studies using a cell-free system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

A two-step mechanism for the interaction of estradiol with rat uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

A non-steroidal estrogen antiagonist 1-(p-2-diethylaminoethoxyphenyl)-1-phenyl-2-p-methoxyphenyl ethanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

An orally active compound with anti-fertility effects in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Substituted Aminoalkoxytriarylhaloethylenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Stereochemistry of geometric isomers of clomiphene: A Correction of the Literature and a Reexamination of Structure‐Activity Relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

7 January 2021

Postcoital contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

7 January 2021

Antioestrogens. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Antiestrogens in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

A new derivative of triphenylethylene: effect on implantation and mode of action in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Mode of action of I.C.I. 46,474 in preventing implantation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Clomiphene protects against osteoporosis in the mature ovariectomized rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Antagonism of estrogen action with a new benzothiophene derived antiestrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Effects of anti-estrogens on bone in castrated and intact female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990017-3

10.1016/S0022-2143(99)90017-3

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10235123